2nd InterAmerican Oncology Conference

“Current Status and Future of Anti-Cancer Targeted Therapies”
13-14 September, 2007

Conference Chairmen

Román Perez Soler, New York, USA
Carlos L. Arteaga, Nashville, USA

Under the Auspices of

Academia Nacional de Medicina
Asociación Médica Argentina
CONICET
Sociedad Argentina de Cancerología
Sociedad Argentina de Hematología
Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Urología
Sociedad Española de Oncología Médica
Universidad de Quilmes
Declared of special scientific interest by Facultad de Medicina, University of Buenos Aires

Faculty

Alex A. Adjei, M.D., Ph.D.
Senior Vice President,
Clinical Research Chair, Department of Medicine
Roswell Park Cancer Institute
Buffalo, NY, USA

Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology.
Div. of Oncology Vanderbilt University School of Medicine
Director, VICC Breast Cancer Program
Nashville, Tennesse, USA

Javier Cortés Castán , M.D.
Hospital Universitario Vall d’Hebron
Barcelona, Spain

Hernán Cortés Funes, M.D.
Department of Medical Oncology
Hospital Universitario “12 de Octubre”
Madrid, Spain

Carlos M. De Castro, M.D.
Clinical Associate Professor in Medicine
Department Medicine – Hematology/Oncology
Duke University Medical Center
Durham, USA

Nora Disis, M.D.
Director, Center for Translational Medicine in Women’s Health
Director, General Clinical Research Center
University of Washington
Seattle, Washington, USA

Janice P. Dutcher, M.D.
Associate Director for Clinical Affairs
Our Lady of Mercy Medical Center
Professor of Medicine
New York Medical College
NY, USA

Herbert I. Hurwitz, M.D.
Associate Professor of Medicine
Clinical Director, Phase I Program
Co-leader GI Oncology Program
Duke University Medical Center
Durham, USA

Scott M. Lippman, M.D.
Charles A. LeMaistre Distinguished Chair in Thoracic Oncology
Chair, Department of Thoracic/Head & Neck Medical Oncology
Professor of Medicine and Cancer Prevention
M.D. Anderson Cancer Center
Houston, TX, USA

Sagar Lonial, M.D.
Assistant Professor of Hematology and Oncology
Director, Translational Research B-cell Malignancy Program
The Emory Clinic
Atlanta, USA

William Pao, MD, Ph.D.
Assistant Member, Human Oncology and Pathogenesis Program
Assistant Attending Physician, Thoracic Oncology Service
Department of Medicine Memorial Sloan-Kettering Cancer Center
NY, USA

Román Perez-Soler, M.D.
Chairman, Department of Oncology
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, NY, USA

Gabriel Rabinovich, M.S., Ph.D.
Associate Professor, University of Buenos Aires
Faculty of Exact and Natural Sciences
Independent Researcher – CONICET (National Research Council Argentina)
Visiting Assistant Professor Immunology
University of Maryland, Baltimore, USA
Cancer Research Institute Fellow
New York, USA

Farhad Ravandi, MD.
Department of Leukemia
University of Texas
M.D. Anderson Cancer Center
Houston, TX, USA

Rafael Rosell, M.D., Ph.D.
Chief, Medical Oncology Service
Scientific Director of Oncology Research
Catalan Institute of Oncology
Hospital Germans Trias i Pujo
Barcelona, Spain

Josep Tabernero, M.D.,Ph.D.
Head, Gastrointestinal Cancer Project
Medical Oncology Department
Vall d’Hebron University Hospital
Barcelona, Spain

John J. Wright, M.D, Ph.D.
Senior Clinical Investigator
Developmental Chemotherapy Section
Investigational Drug Branc
CTEP/NCI/NIH
Bethesda, MD, USA

Sponsors

The supporting companies have no control over the selection of the faculty or the content of the presentations.

PLATINUM SPONSORS

AbraxisGlaxoJanssenMerkPfizerPfizer


GOLD SPONSORS

AMGENBristol-MyersLilly


SILVER SPONSORS

Pierre FabreSchering Plough